Concepedia

Lyndon Kim

LK

Statistics

Publications

31

Citations

4.6K

H-Index

25

Active since

1996

Affiliations

Thomas Jefferson University(Current)

Neurological Surgery

National Institutes of Health

National Cancer Institute

Saint John's Health Center

Lyndon Kim is an author at Thomas Jefferson University specializing in medicine, oncology, and brain tumors.

Publications per year

1996–2023

31

Publications

31

Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

Teri Kreisl, Lyndon Kim, Paul Duic et al. · Journal of Clinical Oncology · 2008 · 1.6K citations · Full text

, , +15

Proteogenomic and metabolomic characterization of human glioblastoma

Liang-Bo Wang, Alla Y. Karpova, Jennifer Kyle et al. · Cancer Cell · 2021 · 692 citations · Full text

, , +17

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 405 citations · Full text

, , +17

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

Patrick Y. Wen, David A. Reardon, Terri S. Armstrong et al. · Clinical Cancer Research · 2019 · 272 citations · Full text

, , +17

Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme

Colin E. Champ, Joshua D. Palmer, Jeff S. Volek et al. · Journal of Neuro-Oncology · 2014 · 223 citations

, , +14

1–5 of 31